News
19 Jan 2022
New Ways of Working in a new era: EORTC new hybrid work model based on collaboration and flexibility
12 Jan 2022
Independent Clinical Cancer Research in the Continuum of Drug Development into Access – for Patient-Centred Cancer Treatment & Care
10 Jan 2022
KEYTRUDA® (pembrolizumab) Showed Statistically Significant Improvement in Disease-Free Survival Versus Placebo as Adjuvant Treatment for Patients With Stage IB-IIIA Non-Small Cell Lung Cancer Regardless of PD-L1 Expression
15 Dec 2021
EHDS: an opportunity to unleash the power of data?
14 Dec 2021
Save and improve citizens’ lives across Europe by continuing vital EU-UK research collaboration
8 Dec 2021
Opportunity with Neoplasia journal – Commissioning Editor Oncology (call for applications)
23 Nov 2021
Results from monotherapy group in UPSTREAM demonstrate trial’s feasibility in head and neck squamous cell carcinoma
17 Nov 2021
EORTC TOLERANCE trial in elderly patients with advanced soft tissue sarcoma receives support from Rising Tide Foundation
10 Nov 2021
Prof. Dr. A.T. van Oosterom (EORTC President 2000-2003)
18 Oct 2021
EORTC Completes Patient Recruitment to Study of Treatment for Rare Cancer High-Grade Uterine Sarcoma
